Effect-site concentration of remifentanil for preventing cough during emergence from sevoflurane or desflurane anesthesia in female elderly patients undergoing laparoscopic cholecystectomy

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0002883

Enrollment

Registered

2018-05-18

Start date

2016-06-17

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : After induction of anesthesia, the anesthesia is maintained with sevoflurane or desflurane according to the assigned group. About 15 minutes before the end of surgery, remifentanil is set at th

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Female elderly patients (60~75yrs) with American Society Anesthesiologist (ASA) physical status I or II who undergoing laparoscopic cholecystectomy with sevoflurane or desflurane will be enrolled in this study.

Exclusion criteria

Exclusion criteria: Patients with predicted difficult airway, body mass index > 30 kg/m2, history of upper respiratory infection (with 2 weeks), respiratory disease, current smokers(within 8 weeks), uncontrolled hypertension or diabetes, moderate to severe coronary artery disease wilil be excluded from the study.

Design outcomes

Primary

Measure	Time frame
presence or absence of cough during anesthetic emergence	—

Secondary

Measure	Time frame
severity of cough during anesthetic emergence with extubation	—

Countries

Korea, Republic of

Contacts

Public ContactHa Yeon Kim

Ajou University Hospital

dreamfy83@naver.com+82-31-219-5689

Outcome results